Davis's Drug Guide
oxyMORphone
General
High Alert Medication: This medication bears a heightened risk of causing significant patient harm when it is used in error.
**REMS Drug**
Pronunciation:
ox-i-mor-fone
To hear audio pronunciation of this topic, purchase a subscription or log in.Trade Name(s)
- Opana
- Opana ER
Ther. Class.
Pharm. Class.
opioid agonists
Controlled Substance Schedule: II
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "OxyMORphone." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2024. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/51571/all/oxyMORphone.
Vallerand AHA, Sanoski CAC, Quiring CC. OxyMORphone. Davis's Drug Guide. F.A. Davis Company; 2024. https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/51571/all/oxyMORphone. Accessed November 22, 2024.
Vallerand, A. H., Sanoski, C. A., & Quiring, C. (2024). OxyMORphone. In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/51571/all/oxyMORphone
Vallerand AHA, Sanoski CAC, Quiring CC. OxyMORphone [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2024. [cited 2024 November 22]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/51571/all/oxyMORphone.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - oxyMORphone
ID - 51571
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - Quiring,Courtney,
BT - Davis's Drug Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/51571/all/oxyMORphone
PB - F.A. Davis Company
ET - 19
DB - Pediatrics Central
DP - Unbound Medicine
ER -
